2008
DOI: 10.1590/s0004-282x2008000500013
|View full text |Cite
|
Sign up to set email alerts
|

Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica

Abstract: -Neuromyelitis optica (NMO) is an inflammatory, demyelinating disease of the central nervous system characterized by the association of a serious myelitis and unilateral or bilateral optic neuritis. The present study aimed to analyze the immunological parameters of NMO patients with diagnosis established based on Wingerchuck et al. (1999) criteria. Production of IgG and IgA antibodies to antigens of MBP, PLP 95-116, MOG 92-106, and the cytokines interleukin-4 (IL-4) and interferon-γ (INF-γ) were assessed by E… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
8
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 33 publications
2
8
0
Order By: Relevance
“…Neuromyelitis optica patients are predominantly female, with a ratio higher than that of multiple sclerosis; the average age at onset is older, usually by the end of the fourth decade of life; and the prevalence of non-white patients is higher than that of other demyelinating diseases 12,13,14,15,16,17,18 . These demographic characteristics were also present in the current Brazilian NMO case series and were similar to those reported for other case series in the country 19,20,21,22 . The exceptions include a younger age at onset in the Adoni et al 21 series, in which only patients with recurrent NMO were analyzed, and lower female-to-male ratios in the Alves-Leon et al 20 and Bichuetti et al 22 series (Table 4).…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Neuromyelitis optica patients are predominantly female, with a ratio higher than that of multiple sclerosis; the average age at onset is older, usually by the end of the fourth decade of life; and the prevalence of non-white patients is higher than that of other demyelinating diseases 12,13,14,15,16,17,18 . These demographic characteristics were also present in the current Brazilian NMO case series and were similar to those reported for other case series in the country 19,20,21,22 . The exceptions include a younger age at onset in the Adoni et al 21 series, in which only patients with recurrent NMO were analyzed, and lower female-to-male ratios in the Alves-Leon et al 20 and Bichuetti et al 22 series (Table 4).…”
Section: Discussionsupporting
confidence: 89%
“…These demographic characteristics were also present in the current Brazilian NMO case series and were similar to those reported for other case series in the country 19,20,21,22 . The exceptions include a younger age at onset in the Adoni et al 21 series, in which only patients with recurrent NMO were analyzed, and lower female-to-male ratios in the Alves-Leon et al 20 and Bichuetti et al 22 series (Table 4). All NMO patients in our series exhibited extensive longitudinal spinal cord lesions in at least one spinal MRI, and none had imaging features suggestive of multiple sclerosis.…”
Section: Discussionsupporting
confidence: 89%
“…Increased production of interleukin-4 in NMO patients indicates an important role of this cytokine in the activation of Th2 regulatory cells [18]. On the other hand, anti-AChR antibody-positive MG is mediated by autoantibodies against AChR in the postsynaptic membrane [4].…”
Section: Discussionmentioning
confidence: 99%
“…NMO lesions show a marked deposition of immunoglobulin and complement in a characteristic perivascular rosette pattern along the outer rim of thickened vessel walls [4]. NMO has been associated with many other autoimmune diseases and even more frequently with the presence of circulating autoantibodies in the absence of clinical manifestations of other diseases [5,6,7]. A specific IgG autoantibody selectively targeting aquaporin-4 (AQP4) has been established as a useful biomarker to distinguish NMO from multiple sclerosis (MS) [3,8,9].…”
Section: Introductionmentioning
confidence: 99%